Here is the complete, structured answer to both questions:
Clinical Case Analysis
Case Summary
A 70-year-old woman from a nursing home presents with:
- 2 days of productive cough, fever (38.9°C/102.1°F), and worsening dyspnea
- HR 104, BP 130/85, RR 28, SpO2 91% on 3L NC
- Altered mental status (slow to answer)
- Dry, warm skin; no JVD, no S3/S4, no lower extremity edema, no calf tenderness
1. Most Likely Diagnosis: Pulmonary Embolism (PE)
Why PE and not Pneumonia?
This is a classic PE "masquerader" - the productive cough and fever superficially suggest pneumonia, but several features point strongly toward PE:
| Feature | This Patient | Significance |
|---|
| Age >70 | Yes | Major PE risk factor |
| Nursing home (immobility) | Yes | Immobilization - major risk |
| Diabetes, hypertension, hypercholesterolemia | Yes | Vascular risk factors |
| HR 104 | Yes | Tachycardia (fails PERC rule) |
| RR 28 | Yes | Tachypnea |
| SpO2 91% on 3L NC | Yes | Hypoxemia (fails PERC rule) |
| Altered mentation | Yes | Suggests significant hemodynamic effect |
| No JVD, no S3/S4 | Absent | Argues against heart failure |
| No calf tenderness/edema | Absent | Does not rule out PE (DVT absent in >70%) |
Key discriminating point: Per Rosen's Emergency Medicine, fever in PE is typically low-grade; a temperature >101.5°F (38.6°C) usually suggests infection - however, this patient's temperature of 38.9°C (102.1°F) is only marginally above that threshold. The absence of JVD, S3/S4 (ruling out heart failure), dry/warm skin, and the constellation of immobility + tachycardia + hypoxia in an elderly nursing home patient makes PE the most likely unifying diagnosis.
PERC Rule: This patient fails PERC on multiple criteria (age >50, HR >100, SpO2 <95%), meaning PE cannot be ruled out clinically - objective testing is required.
Revised Geneva Score:
- Age >65 = 1 point
- HR 75-94 = 3 points (HR 104 would be >95 = 5 points)
- Immobilization (nursing home) = 2 points
- Total: ~8-9 points = Intermediate-to-high probability
2. Management
Step 1: Immediate Stabilization
- Supplemental O2 (already on 3L NC; titrate to SpO2 >94%)
- IV access, continuous cardiac monitoring, pulse oximetry
- 12-lead ECG (look for right heart strain: S1Q3T3, T-wave inversions V1-V4, RBBB)
Step 2: Diagnostic Workup (run in parallel)
- CT Pulmonary Angiography (CTPA) - gold standard, test of choice in this hemodynamically stable patient
- D-dimer - high sensitivity (95-98%), though in this intermediate-high pretest probability patient, a negative result may still not rule out PE; CTPA is preferred
- Troponin + BNP/NT-proBNP - for risk stratification (RV dysfunction markers)
- CBC, BMP, coagulation studies - baseline before anticoagulation
- Chest X-ray - often normal or shows non-specific changes (Westermark sign, Hampton's hump rare)
- Bilateral lower extremity ultrasound - look for DVT source
- ABG if needed to quantify hypoxemia
Step 3: Anticoagulation (initiate IMMEDIATELY - do not wait for confirmatory results)
Per Goldman-Cecil Medicine: "Anticoagulation is the cornerstone of treatment for VTE and should be initiated immediately in patients with suspected pulmonary embolism or DVT even while awaiting the results of confirmatory tests."
First-line options:
- Low-molecular-weight heparin (LMWH) - e.g., enoxaparin 1 mg/kg SC q12h - preferred in most patients
- Direct oral anticoagulants (DOACs) - rivaroxaban or apixaban can be used as monotherapy from the start (rivaroxaban: 15 mg BID x 21 days, then 20 mg daily; apixaban: 10 mg BID x 7 days, then 5 mg BID)
- Unfractionated heparin (UFH) IV - preferred if thrombolysis or procedure is being considered (short half-life, reversible with protamine)
Avoid DOACs if: severe renal impairment, significant drug interactions, or instability requiring thrombolysis.
Step 4: Risk Stratification Guides Further Treatment
| Risk Category | Definition | Treatment |
|---|
| High-risk (massive PE) | Hypotension (SBP <90) or hemodynamic collapse | Anticoagulation + systemic thrombolysis (alteplase 100 mg IV over 2 hrs) or surgical thrombectomy |
| Intermediate-risk | Normotensive + RV dysfunction on echo or elevated troponin | Anticoagulation; consider CDT or thrombolysis if deteriorates |
| Low-risk | No hemodynamic compromise, no RV dysfunction | Anticoagulate; consider early discharge/outpatient treatment |
This patient is currently hemodynamically stable (BP 130/85, no shock) - placing her in at least the intermediate risk category given her tachycardia, hypoxia, and altered mentation. Inpatient admission is appropriate.
Step 5: Thrombolysis - When?
Reserved for high-risk PE (hemodynamic compromise, SBP <90) without contraindications. Not indicated here unless she deteriorates. Per Rosen's: alteplase 100 mg IV over 2 hours is the standard regimen.
Step 6: Duration of Anticoagulation
- Provoked PE (identifiable risk factor like immobility): minimum 3 months
- Extended therapy beyond 3 months depends on whether the risk factor is permanent and the bleeding risk
Step 7: Supportive Care
- Treat fever with acetaminophen (reduces O2 consumption)
- Aspiration precautions given altered mentation
- Consider IVC filter only if absolute contraindication to anticoagulation
Sources: - Rosen's Emergency Medicine, pp. 1202-1211 | Goldman-Cecil Medicine, pp. 805-806